Acquisition of Shares of Icron Technologies Corporation for Investment Purposes

    TORONTO, Dec. 11 /CNW/ - Following the purchase of 286,000 shares of
Icron Technologies Corporation (the "Company") on December 10, 2007 for his
personal account, Steve Laciak, an employee of Dundee Securities Corporation,
acquired beneficial ownership in respect of Mr. Laciak's personal account and
to a much lesser extent the power to exercise control or direction in respect
of an account proprietary to Dundee Securities Corporation managed by Mr.
Laciak on a discretionary basis of a total of 2,480,000 shares of the Company.
As a result of the December 10, 2007 purchase, Mr. Laciak exerts control or
direction over 11.22% of the outstanding shares of the Company.
    The vast majority of shares of the Company under Mr. Laciak's control and
direction are held on his own behalf. The shares were acquired in the ordinary
course of Mr. Laciak's investment activities in respect of Mr. Laciak's
personal holdings, for personal investment purposes, and to a lesser extent to
generate investment returns for Dundee Securities Corporation in respect of
the proprietary account referenced above. Mr. Laciak may purchase or sell
shares of the Company in the future on the open market or in private
offerings, depending on market conditions and other factors material to Mr.
Laciak's investment decisions. At no point of time did or does Mr. Laciak
intend to launch a formal take-over bid or propose a transaction that could
constitute a take-over bid.

For further information:

For further information: Mr. Louis Cavalaris, Vice President & Head of
Institutional Compliance, Dundee Securities Corporation at (416) 350-3057

Organization Profile


More on this organization

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890